Is Abundance of B Cells the Best Biomarker to Predict Immune Checkpoint Inhibitor Response in Head and Neck Squamous Cell Cancers?
Annals of Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined